Dehaier Medical Cooperates With Mindray to Win Procurement Bid
BEIJING, Feb. 12, 2013 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd.
(Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the
development, assembly, marketing and sale of medical devices and homecare
medical products, today announced that it assisted Mindray Medical
International Ltd (NYSE:MR) with a national medical procurement bid for 79
units of Mindray's M7 color Doppler ultrasound machines.
Mr. Ping Chen, Chairman and Chief Executive Officer of Dehaier Medical said,
"The opportunity to cooperate with a well-respected company like Mindray and
the national level of the procurement project made this an important bid for
our company. I am proud of our team's successful bid and believe it reflects
well on our experience participating in governmental procurement projects,
excellent public relations efforts and strong implementation capability. We
expect the project to contribute significantly to revenue this year and set a
firm foundation for our key account business in 2013. We will use this project
and cooperation with Mindray to continue to develop our corporate growth
strategy and to enhance Dehaier's brand awareness."
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly, marketing and sale
of medical products, including respiratory and oxygen homecare medical
products. The company develops and assembles its own branded medical devices
and homecare medical products from third-party components. The company also
distributes products designed and manufactured by other companies, including
medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco
(UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six
patents, ten software copyrights and proprietary technology. More information
may be found at http://www.dehaier.com.cn
About Mindray Medical International Ltd
Mindray is a leading developer, manufacturer and marketer of medical devices
worldwide. Mindray maintains its global headquarters in Shenzhen, China, U.S.
headquarters inMahwah, New Jerseyand multiple sales offices in major
international markets. From the main manufacturing and engineering base
inChina, Mindray supply through its worldwide distribution network a broad
range of products across three primary business segments, namely patient
monitoring and life support, in-vitro diagnostic, and medical imaging
This news release contains forward-looking statements as defined by the
Private Securities Litigation Reform Act of 1995. Forward-looking statements
include statements concerning plans, objectives, goals, strategies, future
events, government approvals or performance, and underlying assumptions and
other statements that are other than statements of historical facts, including
in particular any implications regarding the implementation of the ultrasound
machine procurement agreement. These statements are subject to uncertainties
and risks including, but not limited to, product and service demand and
acceptance, changes in technology, economic conditions, the impact of
competition and pricing, government regulation, future developments in payment
for and demand for medical equipment and services, implementation of and
performance under the joint venture agreement by all parties, and other risks
contained in reports filed by the company with the Securities and Exchange
Commission. All such forward-looking statements, whether written or oral, and
whether made by or on behalf of the company, are expressly qualified by the
cautionary statements and any other cautionary statements which may accompany
the forward-looking statements. In addition, the company disclaims any
obligation to update any forward-looking statements to reflect events or
circumstances after the date hereof.
CONTACT: Dehaier Medical Systems Limited
Dehaier Medical Systems Limited
Press spacebar to pause and continue. Press esc to stop.